| Organism | Drug Class | Company | Drug Name | Alt Name | Drug Status | Notes | AIDS# |
| Epstein-Barr Virus (EBV) | Combination | | Phenylbutyrate and Valganciclovir | | Phase II | Unknown |
|
| Epstein-Barr Virus (EBV) | Combination | HemaQuest Pharmaceuticals Inc. | Ganciclovir and Arginine Butyrate | | Phase II | Terminated |
|
| Epstein-Barr Virus (EBV) | Virus Replication Inhibitor | Epiphany Biosciences; Medivir | Valomaciclovir | EPB-348; MIV-606 | Phase I/II | Completed |
|
| Epstein-Barr Virus (EBV) | Virus Replication Inhibitor | GSK | Valtrex™ | Valacyclovir | Phase I/II | Completed |
070982
|
| Herpes Simplex | Blocks Virus morphogenesis | DeNova Research | Botox™ | Botulinum Toxin A; Onabotulinumtoxin A | Phase II | Recruiting |
|
| Herpes Simplex | DNA Helicase Inhibitor | AiCuris | AIC-316 | | Phase II | Recruiting |
|
| Herpes Simplex | Entry Inhibitor | Shaman Pharmaceuticals | Virend™ | Crofelemer; SP-303T | Phase II | Completed |
071298
|
| Herpes Simplex | Helicase-primase Inhibitor | Astellas Pharma Inc | ASP2151 | | Phase II | Completed |
501812
|
| Herpes Simplex | Unknown | Zicam | Zicam™ | Ionic Zinc | Phase III | Recruitment Unknown |
|
| Herpes Simplex | Unknown | Piramal | PP-9706642 | | Phase II(?) | Trials Reported |
|
| Herpes Simplex | Virucidal | NanoBio Corporation; GlaxoSmithKline | NB-001 | | Phase III | Completed |
|
| Herpes Simplex | Virus Replication Inhibitor | Oclassen Pharmaceuticals | Fialuridine | FIAU | Phase II | Completed |
070971
|
| Herpes Simplex | Virus Replication Inhibitor | Gilead Sciences | Tenofovir gel (GS-1278) | GS-1278; PMPA gel | Phase III | Recruiting |
021800
|
| Herpes Simplex | Virus Replication Inhibitor | Beech Tree Labs, Inc. | BTL-TML-HSV | | Phase I/II | Ongoing, Not Recruiting |
|
| Herpes Simplex | Virus Replication Inhibitor | Gilead Sciences | Forvade™ | Cidofovir gel | Phase II | Completed |
001049
|
| Herpes Simplex | Virus Replication Inhibitor | Parkedale Pharmaceuticals | Vira-A™ | Vidarabine | Phase III | Completed |
007328
|
| Human Cytomegalovirus (HCMV) | HCMV Maturation Inhibitor | Bayer | BAY 38-4766 | | Preclinical | |
085779
|
| Human Cytomegalovirus (HCMV) | HCMV Replication Inhibitor | Trifecta Pharmaceuticals | Artesunate | | Phase III | Completed |
112081
|
| Human Cytomegalovirus (HCMV) | HCMV Terminase-Complex Inhibitor | AiCuris | Letermovir | AIC246 | Phase II | Completed |
499605
|
| Human Cytomegalovirus (HCMV) | UL97 Kinase Inhibitor | GlaxoSmithKline, ViroPharma | Maribavir | Benzimidavir; 1263W94; G1263 | Phase III | Completed |
070966
|
| Human Cytomegalovirus (HCMV) | Virus Replication Inhibitor | Microbiotix, Inc.; Karmanos Cancer Institute | Cyclopropavir | CPV;ZSM-I-62 MBX400 | Phase I | Recruiting |
165691
|
| Human Cytomegalovirus (HCMV) | Virus Replication Inhibitor | Gilead Sciences | Preveon™; Hepsera™ | Adefovir Dipivoxil; bis-POM PMEA | Phase III | Completed |
028595
|
| Human Cytomegalovirus (HCMV) | Virus Replication Inhibitor | Chimerix | CMX001 | Cidofovir prodrug, Chimerix | Phase II | Completed |
104906
|
| Kaposi's Sarcoma-associated Herpesvirus (KSHV) | Matrix Metalloproteinase Inhibitor | Bristol-Myers Squibb | BMS-275291 | BMS-275291 | Phase II | Completed |
|
| Kaposi's Sarcoma-associated Herpesvirus (KSHV) | Protease Inhibitor | Merck | Crixivan™ | Indinavir | Phase II(?) | Completed |
005824
|
| Kaposi's Sarcoma-associated Herpesvirus (KSHV) | Tyrosine Kinase Inhibitor | Novartis | Gleevec™ | Imatinib Mesylate | Phase II(?) | Completed |
|
| Kaposi's Sarcoma-associated Herpesvirus (KSHV) | VEGF Modulator | PTC Therapeutics | PTC299 | | Phase I/II | Terminated |
|